Hematology TimesMogamulizumab is ‘valuable’ option for CTCLFebruary 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsTriple therapy ups response in refractory mantle cell lymphomaFebruary 4, 2018Mantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesIn situ vaccination eradicates lymphoma, other cancersFebruary 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo could treat double-hit lymphomaFebruary 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeBackground color a dermoscopic clue to cutaneous B-cell lymphomaJanuary 30, 2018Lymphoma & Plasma Cell DisordersIndolent LymphomaB Cell Lymphoma
Hematology NewsHodgkin lymphoma survivors are at an increased risk of subsequent ER-negative breast cancerJanuary 30, 2018Hodgkin LymphomaBreast CancerPatient & Survivor CareLymphoma & Plasma Cell Disorders
Hematology NewsFrontline brentuximab vedotin improved Hodgkin lymphoma outcomesJanuary 29, 2018Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesT-cell therapy produces durable responses in rel/ref HLJanuary 26, 2018Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesTreatment costs threaten cancer program growthJanuary 26, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesTechnique could aid treatment of CLLJanuary 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesEC authorizes brentuximab vedotin for CTCLJanuary 23, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesOfatumumab to be pulled from non-US marketsJanuary 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesBright light therapy improves sleep in cancer survivorsJanuary 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesRisks of MGUS persist beyond 30 yearsJanuary 18, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCAR T-cell therapy on fast track in US, EUJanuary 18, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
